Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University College, London
Takeda
Fondazione Italiana Linfomi - ETS
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
University College, London
Eastern Cooperative Oncology Group
Gustave Roussy, Cancer Campus, Grand Paris
Fondazione Michelangelo
Canadian Cancer Trials Group
University of Cologne
M.D. Anderson Cancer Center
SWOG Cancer Research Network
Fondazione Michelangelo
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
American Scitech International
Fondazione Italiana Linfomi - ETS